#Bioinformatics Experts

[catboybiologist]

I made a jumbled mess of a reddit comment about HRT and periods, and somebody (rightfully) pointed out that it was a jumbled mess. They also said that I shouldn't be "misrepresenting myself as an expert". I wasn't trying to do that, but I don't blame them for feeling that way.

I'm not doing a callout, don't go looking for these comments. But every time this happens, I just get a really painful reminder that I'm in a weird zone where people interpret me as an expert for things that I'm not, and that can be really fucking bad.

This is a spiral I get into when I try to think about how I should talk about HRT. Its also the reason why I have so many ignored asks about HRT. It's a huge reason why I'm kinda scared to make anything longer talking about HRT physiology or medication. I fucking get it. Someone comes in, and says they have a biology degree, and they seem like an expert. There's a problem of people not properly understanding who should be treated as an expert, and tbh, its on the part of the people communicating to accurately say what their expertise is.

So. To reiterate.

I'm not an expert. Don't treat me as one. I have a background in molecular genetics and bioinformatics, not hormonal physiology. To me, the hormonal physiology questions about HRT are fun online research rabbit holes, not my profession.

[biopractify]

Free online courses for bioinformatics beginners

🔬 Free Online Courses for Bioinformatics Beginners 🚀

Are you interested in bioinformatics but don’t know where to start? Whether you're from a biotechnology, biology, or computer science background, learning bioinformatics can open doors to exciting opportunities in genomics, drug discovery, and data science. And the best part? You can start for free!

Here’s a list of the best free online bioinformatics courses to kickstart your journey.

📌 1. Introduction to Bioinformatics – Coursera (University of Toronto)

📍 Platform: Coursera 🖥️ What You’ll Learn:

Basic biological data analysis

Algorithms used in genomics

Hands-on exercises with biological datasets

🎓 Why Take It? Ideal for beginners with a biology background looking to explore computational approaches.

📌 2. Bioinformatics for Beginners – Udemy (Free Course)

📍 Platform: Udemy 🖥️ What You’ll Learn:

Introduction to sequence analysis

Using BLAST for genomic comparisons

Basics of Python for bioinformatics

🎓 Why Take It? Short, beginner-friendly course with practical applications.

📌 3. EMBL-EBI Bioinformatics Training

📍 Platform: EMBL-EBI 🖥️ What You’ll Learn:

Genomic data handling

Transcriptomics and proteomics

Data visualization tools

🎓 Why Take It? High-quality training from one of the most reputable bioinformatics institutes in Europe.

📌 4. Introduction to Computational Biology – MIT OpenCourseWare

📍 Platform: MIT OCW 🖥️ What You’ll Learn:

Algorithms for DNA sequencing

Structural bioinformatics

Systems biology

🎓 Why Take It? A solid foundation for students interested in research-level computational biology.

📌 5. Bioinformatics Specialization – Coursera (UC San Diego)

📍 Platform: Coursera 🖥️ What You’ll Learn:

How bioinformatics algorithms work

Hands-on exercises in Python and Biopython

Real-world applications in genomics

🎓 Why Take It? A deep dive into computational tools, ideal for those wanting an in-depth understanding.

📌 6. Genomic Data Science – Harvard Online (edX) 🖥️ What You’ll Learn:

RNA sequencing and genome assembly

Data handling using R

Machine learning applications in genomics

🎓 Why Take It? Best for those interested in AI & big data applications in genomics.

📌 7. Bioinformatics Courses on BioPractify (100% Free)

📍 Platform: BioPractify 🖥️ What You’ll Learn:

Hands-on experience with real datasets

Python & R for bioinformatics

Molecular docking and drug discovery techniques

🎓 Why Take It? Learn from domain experts with real-world projects to enhance your skills.

🚀 Final Thoughts: Start Learning Today!

Bioinformatics is a game-changer in modern research and healthcare. Whether you're a biology student looking to upskill or a tech enthusiast diving into genomics, these free courses will give you a strong start.

📢 Which course are you excited to take? Let me know in the comments! 👇💬

[philosophiesde]

Zoomposium with Dr. Gabriele Scheler: “The language of the brain - or how AI can learn from biological language models”

In another very exciting interview from our Zoomposium themed blog “#Artificial #intelligence and its consequences”, Axel and I talk this time to the German computer scientist, AI researcher and neuroscientist Gabriele Scheler, who has been living and researching in the USA for some time. She is co-founder and research director at the #Carl #Correns #Foundation for Mathematical Biology in San José, USA, which was named after her famous German ancestor Carl Correns. Her research there includes #epigenetic #influences using #computational #neuroscience in the form of #mathematical #modeling and #theoretical #analysis of #empirical #data as #simulations. Gabriele contacted me because she had come across our Zoomposium interview “How do machines think? with #Konrad #Kording and wanted to conduct an interview with us based on her own expertise. Of course, I was immediately enthusiastic about this idea, as the topic of “#thinking vs. #language” had been “hanging in the air” for some time and had also led to my essay “Realists vs. nominalists - or the old dualism ‘thinking vs. language’” (https://philosophies.de/index.php/2024/07/02/realisten-vs-nominalisten/).

In addition, we often talked to #AI #researchers in our Zoomposium about the extent to which the development of “#Large #Language #Models (#LLM)”, such as #ChatGPT, does not also say something about the formation and use of language in the human #brain. In other words, it is actually about the old question of whether we can think without #language or whether #cognitive #performance is only made possible by the formation and use of language. Interestingly, this question is being driven forward by #AI #research and #computational #neuroscience. Here, too, a gradual “#paradigm #shift” is emerging, moving away from the purely information-technological, mechanistic, purely data-driven “#big #data” concept of #LLMs towards increasingly information-biological, polycontextural, structure-driven “#artificial #neural #networks (#ANN)” concepts. This is exactly what I had already tried to describe in my earlier essay “The system needs new structures” (https://philosophies.de/index.php/2021/08/14/das-system-braucht-neue-strukturen/).

So it was all the more obvious that we should talk to Gabriele, a proven expert in the fields of #bioinformatics, #computational #linguistics and #computational #neuroscience, in order to clarify such questions. As she comes from both fields (linguistics and neuroscience), she was able to answer our questions in our joint interview. More at: https://philosophies.de/index.php/2024/11/18/sprache-des-gehirns/

or: https://youtu.be/forOGk8k0W8

[innonurse]

Mark your calendar for these health tech conferences in 2024-2025

- By InnoNurse Staff -

Interested in health technology-related events for fall 2024 and 2025? Fierce Healthcare has compiled a list of key conferences, both virtual and in-person, scheduled for the upcoming seasons.

Read more at Fierce Healthcare

///

Other recent news and insights

Lapsi transforms the stethoscope into a health tracking data platform (TechCrunch)

UK: The Department of Health and Social Care set to review clinical risk standards for digital health technologies (Digital Health)

AI-based cancer test determines if chemotherapy is needed (The Financial Express)

New tool enhances microscopic imaging by eliminating motion artifacts (UC Berkeley/Tech Xplore)

Researchers integrate a fast optical coherence tomography system into neurosurgical microscopes (Optica)

AI model achieves clinical-expert-level accuracy in complex medical scans (UCLA/Medical Xpress)

Bioinformatics reveals the hidden prevalence of repeat expansion disorders (Queen Mary University of London/Medical Xpress)

Ultrasound detects 96% of ovarian cancers in postmenopausal women (University of Birmingham)

AI ‘liquid biopsies’ using cell-free DNA and protein biomarkers could improve early ovarian cancer detection (Johns Hopkins Technology Ventures)

Mammograms show potential for detecting heart disease (UC San Diego/Medical Xpress)

IMRT and proton therapy provide similar quality of life and tumor control for prostate cancer patients (American Society for Radiation Oncology/Medical Xpress)

Machine learning enhances MRI video quality (Graz University of Technology/Medical Xpress)

Robotic surgery for colorectal cancer reduces pain and accelerates recovery (Beth Israel Deaconess Medical Center)

Global human brain mapping project releases its first data set (Allen Institute)

AI could speed up PCR tests, aiding faster DNA diagnostics and forensics (Flinders University/Medical Xpress)

AI-powered apps may detect depression through eye snapshots (Stevens Institute of Technology/Medical Xpress)

[bighermie]

Why This Bioinformatics Expert Believes the COVID-19 Virus Was Edited in a Lab

Why This Bioinformatics Expert Believes the COVID-19 Virus Was Edited in a Lab https://link.theepochtimes.com/mkt_app/epochtv/why-this-bioinformatics-expert-believes-the-covid-19-virus-was-edited-in-a-lab-5618527?utm_source=andshare

[rajdhami01-blog]

Emerging Trends in Pharmaceutical Education 

Pharmaceutical education is experiencing a transformative shift in response to rapid advancements in the field of healthcare and the evolving needs of the global population. As we step into a future characterised by personalised medicine, precision therapies, and breakthrough technologies, the training and education of future pharmacists and pharmaceutical professionals are adapting to keep pace. In this blog, we will bring forth the latest developments and emerging trends in pharmaceutical education. 

According to Statista Pharmaceutical Market Forecast, the pharmaceutical industry has witnessed a rapid metamorphosis, with revenue expected to show an annual growth rate (CAGR 2023-2028) of 5.80%, resulting in a market volume of US$1,478.00bn by 2028, reflecting the sector's exponential growth. This growth is propelled by various factors, including an aging population, the rise of chronic diseases, and the increasing demand for personalised treatments. In response, pharmaceutical education is adapting to equip aspiring pharmacists and professionals with the skills and knowledge needed to navigate this dynamic and ever-evolving industry. 

1. Integration of Technology and Digital Learning 

In recent years, the integration of technology into pharmaceutical education has become ubiquitous. Digital platforms, virtual labs, simulation software, and online courses are revolutionizing the way students learn and engage with the subject matter. Augmented Reality (AR) and Virtual Reality (VR) are being utilized to create immersive learning experiences, allowing students to visualize complex pharmaceutical concepts in a more interactive and dynamic manner. These technologies enhance understanding and retention, ultimately preparing students for the technologically advanced landscape of modern healthcare. 

2. Focus on Interdisciplinary Learning 

Pharmaceutical education is embracing an interdisciplinary approach, fostering collaboration between pharmacy students and professionals from other healthcare domains. Interdisciplinary learning encourages a holistic understanding of healthcare systems and enables students to work seamlessly in a team-based environment. Collaborations with medical practitioners, bioinformatics experts, data scientists, and engineers expose students to diverse perspectives and problem-solving strategies, preparing them to be well-rounded professionals in an interdisciplinary healthcare landscape. 

3. Personalised and Individualised Learning 

Recognizing the unique learning styles and paces of individual students, personalized learning is gaining traction in pharmaceutical education. Tailoring educational experiences to meet the specific needs and preferences of students allows for a more effective learning process. Adaptive learning technologies use data analytics to track student progress and adapt the content and pace of learning accordingly. This approach optimizes comprehension and retention, ensuring that each student achieves their educational goals. 

4. Integration of Pharmacogenomics and Genetics 

Advancements in pharmacogenomics and genetics are transforming pharmaceutical education by necessitating a deeper understanding of how genetic variations influence drug responses. Modern curricula are incorporating in-depth studies of genomics, pharmacogenomics, and genetic testing to equip future pharmacists with the knowledge and skills to provide personalized medication recommendations based on an individual's genetic makeup. This personalized approach improves patient outcomes and reduces adverse reactions. 

5. Emphasis on Soft Skills and Professionalism 

Pharmaceutical education is evolving to place greater emphasis on soft skills and professionalism. Effective communication, leadership, critical thinking, and empathy are essential qualities for pharmaceutical professionals. Educational programs now integrate courses and workshops that enhance these skills, preparing students not only to excel in their technical roles but also to effectively interact with patients, colleagues, and healthcare stakeholders. 

6. Experiential Learning and Practical Exposure 

Traditional classroom-based learning is being complemented with experiential learning and practical exposure in real-world healthcare settings. Internships, externships, and rotations in community pharmacies, hospitals, research laboratories, and pharmaceutical industries provide students with valuable hands-on experience. These opportunities bridge the gap between theory and practice, enabling students to apply their knowledge in real-life scenarios and develop the necessary skills and confidence for their future careers. 

7. Environmental and Global Health Perspectives 

As sustainability and global health become paramount concerns, pharmaceutical education is incorporating curricula that address the environmental impact of pharmaceuticals and global health challenges. Students are exposed to the concepts of eco-friendly pharmaceutical practices, responsible drug manufacturing, and the role of pharmacists in addressing global health issues. This broadens their understanding of the industry's impact on the planet and society, encouraging responsible and ethical practices. 

Pioneering Pharmaceutical Education in India 

Shoolini University stands at the forefront of innovative pharmaceutical education in India. Renowned for its commitment to academic excellence, state-of-the-art infrastructure, and emphasis on holistic development, Shoolini University has emerged as a top choice for students aspiring to excel in the pharmaceutical field. Let's delve into the details of the pharmaceutical education offerings and the esteemed Faculty of Pharmaceutical Sciences at Shoolini University. 

Here are some highlights of Shoolini University's exceptional pharmaceutical education: 

Faculty from prestigious institutions worldwide, including University of Innsbruck (Austria), University of Constance (Germany), Chang Won National University (South Korea), and NIPER. 

Pharma NIRF Rank 41 (All India), reflecting the university's academic prowess and standing in the pharmaceutical education landscape. 

The Faculty of Pharmaceutical Sciences boasts 104+ cutting-edge laboratories across the university, providing students with extensive practical exposure and fostering research and innovation. 

Students receive scholarships and fellowships at both undergraduate (UG) and postgraduate (PG) levels, encouraging academic excellence and reducing the financial burden on students. 

An application-oriented curriculum that prepares students for real-world challenges, ensuring they are industry-ready upon graduation. 

Programs Offered by Shoolini University

Program 1

B Pharmacy 

Duration : 4 years 

Eligibility : 10+2 (PCB/PCM) with minimum 60% marks 

Program 2

B Pharmacy LEET 

Duration : 3 years 

Eligibility : Diploma in Pharmacy with 60% marks from a Pharmacy Council of India approved institution 

Program 3

M Pharma Pharmacology 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 4

M Pharmacy Pharmaceutical Chemistry 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 5

M Pharmacy Pharmaceutics 

Duration : 2 years 

Eligibility : B Pharmacy from an institution approved by the Pharmacy Council of India with minimum 55% marks 

Program 6

PhD Pharma 

Duration : 3 years 

Eligibility : Four-year graduation degree by research or master's degree in related discipline with minimum 55% marks 

In conclusion, Shoolini University is leading the way in pharmaceutical education in India, aligning its programs with the evolving trends and demands of the healthcare industry. Through a focus on innovation, interdisciplinary learning, practical exposure, and a dedicated faculty, Shoolini University equips its students to contribute significantly to the advancement of pharmaceutical sciences and improve healthcare outcomes for individuals and communities. 

[swati3191]

From DNA to Diagnosis: What Happens Inside a Genetic Testing Lab?

Genetic testing may seem like a black box from the outside — you provide a sample, and weeks later, receive a detailed report filled with technical information. But behind the scenes, there’s a meticulous, high-precision process that transforms your DNA into actionable medical insights. Let’s take a closer look at what actually happens inside a modern genetic testing laboratory.

Step 1: Sample Collection and Preparation

It all begins with a simple biological sample — typically blood, saliva, or tissue. Once the sample reaches the lab, it is labeled, logged, and stored under controlled conditions to maintain integrity.

The first laboratory step is DNA extraction, where technicians isolate DNA from the sample using specialized chemical processes or kits. The result is a purified form of DNA ready for further analysis.

Step 2: DNA Quantification and Quality Check

Before testing begins, the extracted DNA is evaluated for quality and quantity. Using tools like spectrophotometers and fluorometers, technicians assess whether the sample has sufficient, high-quality DNA. Only high-integrity samples proceed to the next stage.

Step 3: Genetic Analysis — Sequencing or Targeted Testing

Depending on the clinical question, labs perform different types of genetic analysis:

Targeted Mutation Testing: Looks for known mutations (e.g., BRCA1/BRCA2 for breast cancer)

Panel Testing: Analyzes multiple genes linked to a specific disease (e.g., cardiomyopathy panel).

Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS): Offers a broad look across the entire coding region or full genome to detect rare or unknown genetic variants.

This is usually performed using Next Generation Sequencing (NGS) — a highly sensitive, high-throughput technology that reads millions of DNA fragments simultaneously.

Step 4: Bioinformatics — Interpreting the Code

The sequencing process generates massive amounts of raw data — essentially long strings of A’s, T’s, G’s, and C’s. Bioinformatics specialists use sophisticated software and algorithms to:

Align DNA sequences to a reference genome

Identify genetic variations

Filter out harmless or common variants

Highlight potentially disease-causing mutations

This digital layer is crucial in turning raw DNA sequences into meaningful insights.

Step 5: Clinical Interpretation and Reporting

Once potentially significant variants are identified, clinical geneticists or molecular pathologists interpret them in the context of medical literature, databases, and the patient’s clinical history. They determine whether a mutation is:

Pathogenic (disease-causing)

Likely pathogenic

Variant of uncertain significance (VUS)

Benign or likely benign

A final report is then generated — clear, clinically relevant, and actionable — and shared with the ordering physician or genetic counselor.

Step 6: Quality Control and Accreditation

Throughout every step, quality control is paramount. Labs like Greenarray Genomics Research and Solutions Pvt. Ltd. follow stringent protocols and use certified equipment to ensure accuracy, reproducibility, and compliance with regulatory standards.

Under the guidance of Dr. Sanjay Gupte, our lab in Pune combines advanced instrumentation with expert oversight to maintain the highest standards in genetic diagnostics.

The Journey of Discovery

From a simple swab to sophisticated sequencing, genetic testing is a fusion of biology, technology, and clinical science. Each step — from DNA extraction to diagnosis — plays a vital role in uncovering the genetic factors behind health and disease.

At Greenarray Genomics, we don’t just test genes — we decode possibilities, empower clinicians, and help patients take informed steps toward better health.

[govindhtech]

Quobly Launches High-Fidelity Quantum Emulator with QPerfect

Quobly

Quobly, a quantum microelectronics leader, launched a major software emulator that emulates quantum circuits on classical devices. Developers, researchers, and industry experts may now build and test quantum algorithms on this “perfect” emulator, demonstrated at the France Quantum event and produced with French emulation startup QPerfect. Its immediate accessibility on OVHcloud shows its real-world readiness. This announcement is a major step in Quobly's industrialisation strategy, which includes an exclusive agreement with STMicroelectronics to advance from emulation to commercial quantum hardware.

The emulator is “perfect” since it does not simulate qubit physical defects and can emulate 27 to 31 logical qubits without errors. This stability is needed for accurate algorithm training and testing. The emulator employs QPerfect's language, akin to IBM's Qiskit and Google's Cirq. This strategy simplifies user training and integration by eliminating the need for a proprietary language and ensuring widespread accessibility.

Combinatorial optimisation, notably in commercial logistics, quantum chemistry for materials discovery, and quantitative finance for portfolio management all address concrete needs across significant sectors, making the emulation helpful. It also enhances artificial intelligence, medicinal development, and deep learning. The tool is also used for bioinformatics and defence training and demonstrations, where it has a commercial agreement with the Direction Générale des Armées. Its stable environment encourages public and commercial organisations to participate early, creating quantum readiness before actual machines operate.

The first major release of an ambitious software package is this “perfect” emulator. Future versions will leverage tensor networks and accurate hardware defect and quantum noise modelling to mimic up to 100 qubits.

An exclusive partnership with STMicroelectronics at the end of 2024 integrates the launch into Quobly's industrialisation strategy. This alliance allows large-scale quantum computing systems using STMicroelectronics' 28nm FD-SOI semiconductor volume manufacturing processes. Quobly can control the entire value chain and build a complete ecosystem from software to hardware by adding industrial manufacturing limits into design. This integrated strategy gives a competitive edge in the fast-growing quantum sector.

According to Quobly CEO and co-founder Maud Vinet, “This emulator accelerates the development of the quantum machine and comes before its production.” Emulation tools aid system design and hardware performance in traditional integrated circuit development, she said. “A powerful tool for preparing the transition to scale with the customers,” Vinet said, emphasising its role in preparing clients for growth. She credited this magnitude of industrialisation planning to the “unique partnership with STMicroelectronics.”

Quobly's emulator connects quantum gear's future possibilities to traditional computer. Quobly provides an accurate and easy-to-use environment for developing and testing quantum algorithms, nurturing the knowledge and application foundation essential for quantum computer adoption. This accelerates theoretical potential to quantum solutions.

In Conclusion

According to the material, Quobly has produced a “perfect” quantum emulator for testing quantum algorithms on classical hardware. QPerfect helped design this emulator. It supports 27 to 31 logical qubits without simulated physical faults and works with IBM's Qiskit and Google's Cirq. To prepare defence, banking, logistics, and pharmaceutical industries for quantum computing. This introduction is the first stage in Quobly's software suite and industrialisation strategy with STMicroelectronics to move from emulation to commercial quantum hardware. The initiative takes a measured step to accelerate quantum preparation and bridge the gap between classical computer and quantum capabilities.

[helpexpertassignment]

Future-Ready Biotechnology Assignment Assistance by Global Experts

Require offer assistance with your Biotechnology assignments? Get master direction from the Best Assignment Help Expert, trusted over Singapore, UAE, Canada, UK, USA, Australia, and New Zealand. Our pros provide well-researched, plagiarism-free substance in zones like hereditary designing, atomic science, and bioinformatics. We guarantee convenient conveyance, 24/7 bolster, and scholarly fabulousness at student-friendly costs. Boost your grades and understanding with our proficient Biotechnology Assignment Help—the keen choice for future innovators!

[heriditybio]

Biotechnology Training Programs in Bhubaneswar: A Comprehensive Guide

Biotechnology is a rapidly evolving field that combines biology, chemistry, and technology to develop innovative solutions in healthcare, agriculture, and environmental sustainability. With increasing demand for skilled professionals, biotechnology training programs have become essential for students and professionals looking to advance their careers.

Bhubaneswar, the capital city of Odisha, has emerged as a hub for biotechnology education and research. Several institutes and organizations offer specialized training programs, equipping learners with hands-on experience and industry-relevant skills. Among these, Heredity Biosciences stands out as a leading provider of biotechnology training and summer internships in Bhubaneswar.

This article provides a detailed analysis of biotechnology training programs in Bhubaneswar, covering key institutions, course structures, career prospects, and the role of Heredity Biosciences in shaping the future of biotechnology professionals.

The Growing Importance of Biotechnology Training

Biotechnology is a multidisciplinary field with applications in:

Healthcare (drug development, genetic engineering, diagnostics)

Agriculture (GM crops, biofertilizers)

Industrial Biotechnology (enzyme production, biofuels)

Environmental Biotechnology (waste management, bioremediation)

According to a report by IBEF (India Brand Equity Foundation), the Indian biotechnology industry is expected to reach $150 billion by 2025, creating a surge in demand for trained professionals. Odisha, with its focus on education and research, is positioning itself as a key player in this sector.

Why Choose Bhubaneswar for Biotechnology Training?

Presence of reputed universities and research institutes

Growing biotech startups and industrial collaborations

Government initiatives promoting skill development in life sciences

Top Biotechnology Training Programs in Bhubaneswar

Several institutions in Bhubaneswar offer biotechnology training, ranging from short-term courses to advanced diplomas. Below is an overview of the key programs available:

1. Heredity Biosciences

Established: 2021 Specializations: Molecular Biology, Genetic Engineering, Clinical Research, Bioinformatics

Heredity Biosciences is a trusted provider of research and training services to hospitals, life sciences institutes, and pharmaceutical companies. Their programs are designed by experienced scientists and industry professionals, ensuring practical and industry-aligned training.

Key Offerings:

Biotechnology Summer Internships in Bhubaneswar – Hands-on training in lab techniques, data analysis, and research methodologies.

Specialized Certification Courses – Covers PCR, Gel Electrophoresis, CRISPR, and Next-Generation Sequencing (NGS).

Industry Collaborations – Partnerships with pharmaceutical and healthcare organizations for real-world exposure.

Why Choose Heredity Biosciences?

Expert-led training with professionals from life sciences and healthcare industries.

State-of-the-art lab facilities for practical learning.

Placement assistance for internships and jobs in biotech firms.

2. Institute of Life Sciences (ILS), Bhubaneswar

Offers PhD programs, internships, and workshops in biotechnology.

Focus areas: Cancer Biology, Infectious Diseases, Plant Biotechnology.

Collaborates with CSIR, DBT, and ICMR for research projects.

3. KIIT University – School of Biotechnology

B.Tech, M.Tech, and PhD programs in Biotechnology.

Industry-oriented curriculum with internships at leading biotech companies.

4. Centurion University – Department of Biotechnology

Offers B.Sc, M.Sc, and Diploma courses in Biotechnology.

Skill-based training in fermentation technology, bioinformatics, and genetic engineering.

5. SOA University – Department of Biotechnology

Integrated M.Sc in Biotechnology with research-focused training.

Collaborations with biotech industries for student placements.

Career Prospects After Biotechnology Training

Completing a biotechnology training program in Bhubaneswar opens doors to various career opportunities, including:

1. Research & Development (R&D)

Roles: Research Scientist, Lab Technician, Bioinformatics Analyst

Employers: Pharmaceutical companies, research labs, universities

2. Healthcare & Clinical Research

Roles: Clinical Research Associate, Medical Writer, Genetic Counselor

Employers: Hospitals, diagnostic centers, CROs (Contract Research Organizations)

3. Agricultural Biotechnology

Roles: Agricultural Scientist, Bioprocess Engineer

Employers: Agri-biotech firms, seed companies, government research bodies

4. Industrial & Environmental Biotechnology

Roles: Quality Control Analyst, Environmental Consultant

Employers: Biotech industries, environmental agencies

Salary Expectations

Entry-level positions: ₹3-5 LPA

Mid-level scientists: ₹6-10 LPA

Senior researchers/PhDs: ₹12-20 LPA+

(Source: Naukri.com, Glassdoor India)

Why Biotechnology Summer Internships Matter

Internships provide hands-on experience, industry exposure, and networking opportunities. Heredity Biosciences offers summer internships in Bhubaneswar, allowing students to:

Work on real research projects under expert guidance.

Learn advanced techniques like PCR, ELISA, and DNA sequencing.

Gain certification to enhance employability.

Success Stories

A student from Ravenshaw University secured a research position at a leading biotech firm after completing an internship at Heredity Biosciences.

A KIIT biotechnology graduate credited their industry readiness to hands-on training received during a summer internship.

Government and Industry Support for Biotechnology in Odisha

The Odisha government and central agencies are actively promoting biotechnology through:

Biotech Policy 2021 – Incentives for biotech startups and skill development.

DBT (Department of Biotechnology) funding for research projects.

Collaborations with institutes like ILS and IIT Bhubaneswar.

Conclusion: Choosing the Right Biotechnology Training Program

Bhubaneswar offers diverse biotechnology training programs, catering to students and professionals at different career stages. Heredity Biosciences stands out for its industry-aligned courses, expert faculty, and internship opportunities, making it a top choice for aspiring biotechnologists.

Whether you are a student seeking hands-on training or a professional looking to upskill, enrolling in a biotechnology program in Bhubaneswar can be a game-changer for your career.

Key Takeaways:

For those looking to kickstart their biotechnology career, enrolling in a training program or summer internship in Bhubaneswar is a strategic move toward success.

[bisresearch0]

Latin America NGS Market - Analysis and Forecast, 2024-2034 | BIS Research

What is Latin America NGS market?  

The Latin America next-generation sequencing (NGS) market refers to the comprehensive application of NGS technologies for clinical diagnostics, translational research across Latin American countries. This market includes instruments, such as sequencers, and consumables, such as reagents, kits, software, and services. 

Next-generation sequencing (NGS) is transforming healthcare by enabling comprehensive genomic analysis for personalized medicine. NGS facilitates the use of targeted medicines, accurate tumor profiling, and the discovery of actionable mutations in oncology. 

What is the market size of the Latin America NGS market? 

In 2024, The Latin America NGS Market was valued at $268.04 million. It is projected to grow at a compound annual growth rate (CAGR) of 8.34%, reaching $597.20 million by 2034.

What are the emerging trends in the Latin America market?

Growing Adoption of Personalized Medicine: The Latin America NGS market is growing rapidly due to its expanding role in oncology and infectious disease research, driven by the rising demand for precision medicine and its critical applications in cancer mutation detection and virological studies such as COVID-19 and HBV.

Increasing Local Production and Infrastructure: Countries in Latin America are investing in local NGS infrastructure by establishing genomics centers and bioinformatics training programs, such as the CABANA model in Mexico, to reduce reliance on international services and enhance regional genomic research capabilities.

Expansion of Genomic Data Accessibility: Efforts to increase the accessibility of genomic data are growing, with partnerships such as Lifebit, Omica.bio, and gen-t in Brazil and Mexico enhancing local data representation in global datasets to support more inclusive and accurate population health research.

What are the main challenges or barriers to NGS adoption in Latin America?

Cost-Effectiveness: The high expense of next-generation sequencing (NGS) testing continues to prevent its broad use in the region, which in turn prevents the Latin America NGS market from expanding, especially in countries with much lower average incomes like Brazil, Mexico, and Argentina. Notwithstanding worldwide cost decreases, issues with affordability still prevent NGS from being fully incorporated into regional healthcare systems.

Lack of Funding and Reimbursement:The region's public healthcare systems lack the funds necessary to build the necessary infrastructure for genetic testing, which forces reliance on expensive private labs and impedes the expansion of the Latin American NGS industry. NGS uptake and sustainability in the region are further limited by the high cost of clinical exome sequencing and low reimbursement rates, especially in the public sector.

Lack of Education, Awareness, and Specialists: One of the main obstacles to the wider adoption of genomic technologies in Brazil is the lack of knowledge among patients and healthcare professionals about these technologies, including whole genome and exome sequencing, as well as a lack of medical education and specialized professionals. The efficient use of these technologies is hampered by this knowledge gap, unclear guidelines, and restricted access to experts.

Get Informed: Explore the Influence of Increasing Investments in The Latin America NGS Market Market – Access Our Sample Report!

Learn more about Healthcare Vertical. Click Here!

Conclusion

The Latin America NGS market is poised for significant growth, driven by increasing demand for personalized medicine, advancements in genomic infrastructure, and expanding research collaborations. Opportunities in fields including growing genetic data, setting up diagnostic centers, and incorporating NGS into healthcare systems present a bright future despite obstacles like exorbitant costs, a lack of funding, and a shortage of skilled workers. The Latin American NGS market is anticipated to play a significant role in the advancement of global healthcare as local genomic capabilities increase and accessibility improves.

[sumitkanth7]

BSc Biochemistry Program – REVA University, Bangalore

BSc in Biochemistry at REVA University blends core biochemical principles with biotechnology and genetics. The curriculum includes molecular biology, enzymology, bioinformatics, and lab techniques, supported by fully equipped labs and expert faculty guidance. Students participate in research projects, seminars, and internships to develop analytical and experimental skills. With strong industry linkages and career support, REVA nurtures graduates for roles in pharmaceuticals, biotech, academia, and research. An ideal choice for aspiring scientists committed to advancing in life sciences.

[missionvision-biz]

Release

FOR IMMEDIATE RELEASE

MISSIONVISION.BIZ LLP Officially Incorporated to Drive Innovation in Cloud, AI, Data, and Genomics Solutions

New Delhi, India – May 29, 2025 – MISSIONVISION.BIZ LLP, a forward-thinking technology firm specializing in cloud platforms, AI-driven analytics, and data infrastructure, proudly announces its official incorporation as a Limited Liability Partnership on May 29, 2025.

Founded with the vision of delivering scalable, intelligent, and future-ready solutions, MISSIONVISION.BIZ LLP is committed to helping organizations accelerate digital transformation. The company delivers robust services across SaaS, PaaS, IaaC, and deep learning technologies—while also expanding into cutting-edge genomics and bioinformatics research support.

“Formalizing our business structure is a significant step toward our long-term mission,” said Rajat Patyal, Managing Partner of MISSIONVISION.BIZ LLP. “Our incorporation enables us to scale both technologically and geographically, bringing advanced capabilities in AI, data science, and genomics to the forefront.”

In addition to its digital innovation portfolio, MISSIONVISION.BIZ LLP now offers specialized solutions in genomics data processing, including:

RNA-seq (RNA sequencing) analysis

ChIP-seq (Chromatin Immunoprecipitation sequencing)

Variant calling, genome alignment, and annotation

Bioinformatics pipelines for large-scale biomedical datasets

Key Focus Areas:

Cloud and DevOps Automation

Predictive Analytics & Machine Learning

Scalable API and SaaS Product Development

Data Migration & Infrastructure Modernization

Genomics & Bioinformatics Data Services

MISSIONVISION.BIZ LLP operates with a lean, expert-driven team based in New Delhi, India, and collaborates globally through its freelancer and partner network. The company is also building strategic partnerships across APAC with leaders in cloud, data, and scientific computing domains.

For media inquiries, partnership opportunities, or more information, please contact:

Rajat Patyal Managing Partner, MISSIONVISION.BIZ LLP Email: rajat.patyal@icloud.com Website: www.missionvision.biz

[deshpandeisha]

Global Protein Sequencing Market Trends and Forecasts : Innovations and Growth Drivers

The Protein Sequencing market is expected to grow from an estimated USD 1524.6 million in 2024 to USD 2170.0 million in 2033, at a CAGR of 4.0%. The market is often driven by biotechnology and pharmaceutical businesses in developing and established nations, focusing on heading in the right direction in drug development. However, De novo peptide sequencing technologies and analytical approaches to the usage of neural community models have currently evolved new enterprise capabilities.

The latest research on the Protein Sequencing market applies both qualitative and quantitative data analysis to present an overview of the future adjacencies around the Protein Sequencing industry. An extensive study of the product application and services conducted by subject matter experts assessing the Protein Sequencing market will help product owners to make a wise decision. From analyzing which products companies should produce, expand to how brands should position their product the study covers all that business owners require meeting the buyers’ requirement.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/3233

Competitive Terrain:

The global Protein Sequencing industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Thermo Fisher Scientific, Inc., Shimadzu Corporation, Agilent Technologies, Inc., Rapid Novor, Inc., Charles River Laboratories, Proteome Factory AG, Selvita, Bioinformatics Solutions Inc., Creative Proteomics, Alphalyse

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Protein Sequencing market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Protein Sequencing market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Protein Sequencing market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/3233

Market Segmentations of the Protein Sequencing Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Protein Sequencing market on the basis of product, application, and region:

Segments Covered in this report are:

Protein Sequencing Market Segmentation Analysis

Product & Service Outlook (Revenue, USD Million; 2020-2033)

Protein Sequencing Products

Reagents & Consumables

Instruments

Software

Protein Sequencing Services

Application Outlook (Revenue, USD Million; 2020-2033)

Bio-therapeutics

Genetic Engineering

Others

End Use Outlook (Revenue, USD Million; 2020-2033)

Academic Institutes & Research Centers

Pharmaceutical & Biotechnology Companies

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/protein-sequencing-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/3233

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Nanoceramics Powder Market | Minimal Residual Disease Testing Market

Latest Report:  Molecular Sieves Market | Microfluidics Prototype Market

[industrystudyreport]

Gene Silencing Market: Targeting Diseases at Their Genetic Roots

Gene Silencing Market Growth & Trends

The global Gene Silencing Market is on a rapid growth trajectory, expected to reach USD 21.29 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 13.8% from 2025 to 2030. This significant expansion, as highlighted in a new report by Grand View Research, Inc., is primarily driven by the increasing recognition of genetic disorders and the urgent need for effective therapeutic solutions.

Advancements in Gene Silencing Technologies

Over recent years, breakthroughs in gene silencing technologies have been pivotal. These include:

RNA interference (RNAi): A natural biological process where RNA molecules inhibit gene expression.

Antisense oligonucleotides (ASOs): Short synthetic DNA or RNA molecules that bind to specific mRNA sequences, preventing protein synthesis.

CRISPR-based approaches: Gene editing tools that can be adapted to "silence" specific genes.

These advancements have opened new avenues for treating previously untreatable genetic diseases. As research intensifies, pharmaceutical and biotechnology companies are allocating more resources to developing gene silencing therapies to address the unmet medical needs of patients suffering from conditions such as Huntington's disease, muscular dystrophy, and various rare cancers. This growing demand for innovative, targeted therapies is a key driver for the market.

Impact of the COVID-19 Pandemic

The COVID-19 pandemic, despite its disruptive nature, inadvertently underscored the importance of gene-based therapies and accelerated the development of gene silencing technologies. During the pandemic, increased funding and collaboration between research institutions and pharmaceutical companies led to the rapid development of vaccine technologies, demonstrating the potential of gene silencing strategies for tackling a wide range of diseases. Moreover, the pandemic fostered a greater focus on genetic research and innovation in drug discovery, intensifying the need for gene silencing solutions in areas such as viral infections, cancer treatment, and autoimmune disorders. Consequently, gene silencing technologies have gained more prominence, positioning them as a critical component in the future of precision medicine.

Role of Supporting Services

The increasing availability of gene silencing-related services has further fueled market expansion. Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) have become indispensable partners for biotech and pharmaceutical companies engaged in developing gene silencing therapies. These service providers offer specialized expertise in:

Clinical trials management

Regulatory compliance

Scalable manufacturing

By leveraging these services, companies can achieve faster and more cost-effective development of gene silencing-based drugs. The pandemic particularly highlighted the need for robust and scalable production systems, driving further demand for services that support gene therapy development. This trend is expected to continue as the pipeline for gene silencing products expands and as companies strive to meet the increasing demand for these advanced therapeutic options.

Curious about the Gene Silencing Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Gene Silencing Market Report Highlights

By product & service, services is expected to witness the fastest growth with a CAGR of 14.2% during the forecast period. The complexity of gene silencing techniques has created a need for expert support in clinical trial management, regulatory guidance, and bioinformatics analysis. This rising demand for customized solutions and end-to-end services is fueling market expansion

By application, the drug discovery & development segment dominated the market and captured the largest revenue share in 2024. Advances in high-throughput screening, bioinformatics tools, and genomic databases have enhanced target identification and validation processes and are expected to fuel global market growth

By end use, the pharmaceutical & biotechnology companies segment dominated the market and accounted for the largest revenue share in 2024. The market is driven by the increasing focus on precision medicine and the potential of gene-based therapies to treat a wide range of genetic disorders, cancers, and rare diseases

North America held the largest share of 48.23% in 2024. The presence of a population with high susceptibility to rare diseases, increased market penetration rates, and technologically advanced healthcare infrastructure support the region’s growth

A few of the key market players include Revvity, Inc., Danaher, Agilent Technologies, GenScript, Merck KGaA, Thermo Fisher Scientific, Inc., Illumina, Bio-Rad Laboratories, Bio-Techne, New England Biolabs, Inc.

Gene Silencing Market Segmentation

Grand view research has segmented the global gene silencing market based on product & service, application, end use, and region:

Gene Silencing Product & Service Outlook (Revenue, USD Billion, 2018 - 2030)

Products

RNAi                       

miRNA

siRNA

Others

CRISPR-Cas9

CRISPR Kits & Reagents

CRISPR Libraries

Others

Antisense Oligonucleotides   

Others

Services                     

Gene Silencing Application Outlook (Revenue, USD Billion, 2018 - 2030)

Drug Discovery & Development        

Neurology

Oncology

Infectious Diseases

Metabolic Diseases

Others

Therapeutics Manufacturing 

Agricultural Applications        

Others

Gene Silencing End Use Outlook (Revenue, USD Billion, 2018 - 2030)

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

CROs & CMOs

Others

Download your FREE sample PDF copy of the Gene Silencing Market today and explore key data and trends.

[hypeptide]

Phage Display Services: Accelerate Your Peptide Discovery with KS-V Peptide

In the world of modern drug development and molecular diagnostics, phage display technology has become a powerful tool for identifying high-affinity peptide ligands, antibodies, and proteins. At KS-V Peptide, we provide end-to-end phage display services to help researchers and biotech companies uncover novel therapeutic candidates with speed and precision.

What is Phage Display?

Phage display is a molecular technique that uses bacteriophages to connect proteins with the genetic information that encodes them. This method allows for high-throughput screening of peptide or protein libraries to discover molecules that bind to a target of interest, such as a receptor, enzyme, or disease marker.

Why Choose KS-V Peptide’s Phage Display Platform?

At KS-V Peptide, our phage display platform is built on deep expertise and advanced infrastructure. We offer:

✅ Diverse peptide libraries including linear, cyclic, and customized libraries

✅ High-throughput screening and panning against a wide range of targets

✅ Expert bioinformatics analysis for sequence enrichment and affinity ranking

✅ Rapid turnaround time with detailed technical support throughout the project

Whether you need antibody mimetics, target-binding peptides, or molecular probes, our platform is designed to deliver high-specificity hits that accelerate your research or drug development pipeline.

Application Scenarios

Our phage display services are suitable for a broad range of applications:

🔬 Therapeutic peptide discovery

🧬 Biomarker identification

🧫 Antimicrobial peptide screening

💊 Drug delivery targeting

🔗 Peptide-drug conjugate development (PDCs)

Customized Phage Display Library Construction

Looking for a tailored solution? We specialize in constructing custom phage display peptide libraries based on your specific research needs. Our team works closely with you to design and synthesize libraries that reflect your target binding preferences, amino acid composition, and structural features.

One-Stop Phage Display Service Workflow

Our end-to-end workflow includes:

Library design & synthesis

Biopanning (target screening)

Clone selection and sequencing

Binding affinity verification

Data analysis and reporting

From concept to candidate, we ensure high-quality and reliable results at every step.

Why KS-V Peptide?

With years of experience in synthetic peptide development and a proprietary KPDS™ Platform, KS-V Peptide stands out as a trusted partner for biotech, pharma, and academic clients worldwide.

🌍 Global client base

🧪 Robust lab infrastructure

💡 Innovative technology platform

👨‍🔬 Scientific consulting by peptide experts

Get Started Today

If you are looking for reliable, efficient, and innovative phage display services, KS-V Peptide is your ideal partner. Contact us to discuss your project needs and receive a customized service proposal.

👉 Visit our service page: https://www.ks-vpeptide.com/phage-display-services.html